KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Other Working Capital Changes: 2018-2024

Historic Other Working Capital Changes for Castle Biosciences (CSTL) over the last 7 years, with Dec 2024 value amounting to -$1.3 million.

  • Castle Biosciences' Other Working Capital Changes fell 107.63% to -$161,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 8.97%. This contributed to the annual value of -$1.3 million for FY2024, which is 251.29% down from last year.
  • Castle Biosciences' Other Working Capital Changes amounted to -$1.3 million in FY2024, which was down 251.29% from $852,000 recorded in FY2023.
  • In the past 5 years, Castle Biosciences' Other Working Capital Changes ranged from a high of $8.3 million in FY2020 and a low of -$8.3 million during FY2021.
  • In the last 3 years, Castle Biosciences' Other Working Capital Changes had a median value of $852,000 in 2023 and averaged $262,333.
  • As far as peak fluctuations go, Castle Biosciences' Other Working Capital Changes surged by 554.39% in 2020, and later slumped by 251.29% in 2024.
  • Castle Biosciences' Other Working Capital Changes (Yearly) stood at $8.3 million in 2020, then tumbled by 200.00% to -$8.3 million in 2021, then spiked by 114.66% to $1.2 million in 2022, then plummeted by 30.39% to $852,000 in 2023, then crashed by 251.29% to -$1.3 million in 2024.